Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biocytogen Re-organizes into Preclinical Service and Drug Discovery Divisions

publication date: Aug 31, 2023

Beijing Biocytogen Pharma restructured its various operations into two major business divisions: “BioMice™” for the company’s wide range of preclinical services, and an unnamed division specializing in discovery of novel antibody drugs for out-licensings and partnerships. The company said it would release more information about the drug discovery division soon, which could mean a spin-out, eventual IPO, or maybe just a division name. Using its proprietary mice platforms, Biocytogen discovers fully human monoclonal and bispecific/multispecific antibodies and nanobody drugs. Biocytogen has signed 50 therapeutic antibody co-development/out-licensing/transfer agreements and 42 RenMiceTM licensing projects worldwide. More details....

Stock Symbol: (HK: 02315)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here